Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ph I Vorinostat in the Treatment of Advanced Staged Oropharyngeal Squamous Cell Carcinoma

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2015 by Ohio State University Comprehensive Cancer Center
Sponsor:
Collaborator:
National Comprehensive Cancer Network
Information provided by (Responsible Party):
Theodoros Teknos, Ohio State University Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT01064921
First received: February 5, 2010
Last updated: June 25, 2015
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: August 2015 (Final data collection date for primary outcome measure)